Exane Derivatives’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Exane Derivatives’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-138	Closed	-$795	–	1052
2022 Q1	$795	Buy	+138	New	+$1.24K	﹤0.01%	825
2021 Q4	–	Sell	-1,111	Closed	-$29.1K	–	1105
2021 Q3	$29.1K	Sell	1,111 -229	-17%	-$8.44K	0.01%	667
2021 Q2	$63.6K	Sell	1,340 -4,264	-76%	-$191K	0.01%	612
2021 Q1	$258K	Sell	5,604 -343	-6%	-$16.4K	0.07%	256
2020 Q4	$255K	Buy	5,947 +3,830	+181%	+$145K	0.07%	273
2020 Q3	$86.3K	Buy	+2,117	New	+$105K	0.03%	323

Other funds holding TRHC

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Exane Derivatives's TRHC Position: Q2 2022 in Review

Exane Derivatives sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 138 shares — an estimated $795 sold.

Exane Derivatives first reported a position in TRHC in Q3 2020 and held it in 6 quarters. The position peaked at $258K in Q1 2021. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

Exane Derivatives reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 138 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $795.
Exane Derivatives first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Exane Derivatives's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $258K in Q1 2021.
96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.